Cardio Diagnostics Holdings Inc. (CDIO)
Nasdaq: CDIO · In Vitro & In Vivo Diagnostic Substances · Chicago, IL · filing with the SEC since 2021
Filings
183 filings since 2017 beside 113 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Aug 5, 2026.
Filings a yearinsider forms included
216368694728
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Dec 4, 2024.SEC letters: 11 in the last 36 months, the newest May 21, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
May 13, 2025
8-K items 3.03, 5.03, 7.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
May 12, 2025
40 of 183 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.